GO
Loading...

Pfizer 'back on the attack'

Monday, 12 May 2014 | 5:05 AM ET

Pfizer is "back on the attack" and trying to make sure the takeover of AstraZeneca is seen as being "all about science and medicine", CNBC's Catherine Boyle reports.